Abstract:Macrophages are indispensable cellular component in both innate immunity and adaptive immunity. Macrophages show great plasticity and can be specifically shaped by microenvironments in both homeostatic and pathological states. In tumor microenvironments, macrophages are educated to M2-like phenotypes, which are believed to have pro-tumor effects. Applications targeting M2-like tumor-associated macrophages (TAMs) improved outcome in various solid tumors. The significance of macrophages in hematopoietic malignancies was reported and leukemia-associated macrophages (LAMs) have been suggested. However, the phenotypic characteristics of LAMs in different leukemic microenvironments and whether in vivo targeting the LAMs could eliminate their pro-leukemic effects in leukemic microenvironments have not been established. In this study, we analyzed clinical relevance of macrophages in human acute myeloid leukemia (AML), studied phenotypic evolution of bone marrow (BM) and spleen (SP) LAMs in mouse AML and T cell acute lymphoblastic leukemia (T-ALL) models, explored mechanism leading to different LAM phenotypes and tried to eliminate pro-leukemic effects by reprogramming LAMs to have more M1-associated characteristics. The results showed that more CD163 positive M2-like LAMs but not CD68 positive total LAMs correlated with worse prognosis in AML patients. Heterogeneity of LAM activation in tissue-specific leukemic niches was observed in both AML and ALL models, i.e. in SP niche LAMs evolved with more M2 characteristics while in BM niche LAMs evolved with more M1 characteristics. Furthermore, IRF7 contributed to M1 characteristics through the activation of SAPK/JNK pathway. Moreover, targeting IRF7-SAPK/JNK pathway to induce more M1 characteristics in LAMs attenuated their pro-leukemic effects both in vitro and in vivo, and contributed to prolonged survival in leukemia mice. Our study provides the first evidence on how macrophages respond differently to different leukemic niche and the potential target for macrophage based immuno-therapy strategy against leukemia.

Hepatic Leukemia-Associated Macrophages Exhibit a Pro-Inflammatory Phenotype in Notch1-induced Acute T Cell Leukemia.

Hepatic Leukemic Microenvironment Educates Leukemia-Associated Macrophages to a Pro-Inflammatory Phenotype in Notch1-Induced Acute T Cell Leukemia

Organ-Specific Microenvironment Modifies Diverse Functional and Phenotypic Characteristics of Leukemia-Associated Macrophages in Mouse T Cell Acute Lymphoblastic Leukemia

Characterization of Peritoneal Leukemia-Associated Macrophages in Notch1-induced Mouse T Cell Acute Lymphoblastic Leukemia.

Leukemia-Associated Macrophages Educated by Organ-Specific Leukemic Microenvironment Acquire Diverse Functions and Gene-Expression Signatures

THE PHENOTYPIC CHARACTERISTICS OF LEUKEMIA-ASSOCIATED MACROPHAGES ARE SHAPED BY ORGAN-SPECIFIC LEUKEMIC MICROENVIRONMENTS AND TARGETING IRF7-SAPK/JNK PATHWAY ELIMINATES THEIR PRO-LEUKEMIC EFFECTS

Notch signaling via Wnt regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma.

Leukemia Cells Attenuate the Response of Leukemia-Associated Macrophages to Lps by Down Regulation of Tlr4

Integrated Single Cell Analysis Reveals An Atlas of Tumor Associated Macrophages in Hepatocellular Carcinoma

[Expression of P2X Family Receptors in Peritoneal Macrophages of Mouse with Acute T Lymphoblastic Leukemia].

Identification of a Novel Signature Based on Macrophage-Related Marker Genes to Predict Prognosis and Immunotherapeutic Effects in Hepatocellular Carcinoma.

Peritoneal Resident Macrophages in Mice with MLL-AF9-induced Acute Myeloid Leukemia Show an M2-like Phenotype.

Functional Expression of P2X Family Receptors in Macrophages is Affected by Microenvironment in Mouse T Cell Acute Lymphoblastic Leukemia.

Macrophages in Leukemia Microenvironment

Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

Availability of an inflammatory macrophage niche drives phenotypic and functional alterations in Kupffer cells

CSF-1R inhibition disrupts the dialog between leukaemia cells and macrophages and delays leukaemia progression

Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression

Macrophages Reprogrammed by Lung Cancer Microparticles Promote Tumor Development Via Release of IL-1β.

Figure S2 from Monocyte-Derived Leukemia-Associated Macrophages Facilitate Extramedullary Distribution of T-cell Acute Lymphoblastic Leukemia Cells

Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20/CCR6 axis in human hepatocellular carcinoma